Case Overview
This case is about a 71-year-old woman from the United States who has lived with chronic pain for many years. The pain affects several parts of her body, especially her left shoulder, knees, ankle, hips, lower back, and spine. It has made daily activities, sleep, exercise, balance, and her confidence in movement more difficult.
The patient worked hard to stay healthy. She did not drink alcohol or smoke, and she regularly took supplements like multivitamins, calcium, probiotics, vitamin E, fish oil, medicinal mushrooms, spirulina, and chlorella. She also used cannabis to help manage pain and sleep, and preferred to avoid long-term use of pain or prescription medications when possible.
1. Symptom Background and Previous Treatment History
The patient shared that she has had chronic muscle and joint pain for about 15 years. Her main issue was pain in her left shoulder, along with pain in other parts of her body.
Earlier medical records noted that her left shoulder pain had lasted a long time. It got worse with activity and felt better with rest. The pain made it hard for her to do daily tasks and sleep well. She had tried several non-surgical treatments, such as:
Physical therapy
Cortisone injections
Anti-inflammatory medication
Activity modification to reduce joint stress
However, these approaches only provided temporary relief. However, these treatments only helped briefly and did not produce lasting improvement. Doctors had talked with her about surgery, including a total shoulder replacement, because scans and notes showed moderate to severe osteoarthritis in her left shoulder joint. a history of left knee surgery due to a meniscus tear and a previous hysterectomy. Over the past several years, she also reported low energy and depressive symptoms, which may have been related to chronic pain, poor sleep, and reduced quality of life.
2. Medical Report
MRI findings showed degenerative changes in both the cervical and lumbar spines. Lumbar spine MRI showed lumbar spondylosis and degenerative disc disease, with mild central spinal canal stenosis at L3-4 and L4-5. It also showed foraminal stenosis at L4 and L5, with nerve root compression at some levels.
Figure 1 : Baseline left shoulder X-ray before stem cell therapy, used as a pre-treatment reference for structural comparison.
Figure description: Baseline left shoulder X-ray images showing the patient’s shoulder structure before receiving stem cell therapy. The images are presented in two radiographic views to document the pre-treatment condition and provide a visual reference for future comparison after regenerative treatment.
Cervical spine MRI showed cervical spondylosis and degenerative disc disease, with multilevel neural foraminal stenosis and nerve root compression involving C4, C5, C6, and C7. The report noted no acute vertebral collapse, and the cervical cord was unremarkable.
Blood test results from 2024 showed several values within acceptable ranges, including kidney function, liver enzymes, vitamin D, and hs-CRP. However, some values required monitoring, including HbA1c at 6.1% (prediabetes range), elevated total cholesterol and LDL, elevated ferritin, and low insulin. Overall, her pain was not caused by just one problem. Several factors played a role, including osteoarthritis, spinal degeneration, nerve root compression, stiffness, soft-tissue inflammation, and limited mobility. A certain scientific rationale for Soft-Tissue Cell Therapy May Support This.
Condition
Mesenchymal stem cells (MSCs) are being studied in regenerative medicine for their ability to release signals such as cytokines, growth factors, and extracellular vesicles. These signals help control inflammation, allow cells to communicate, and support tissue repair. For conditions like chronic joint pain, osteoarthritis, shoulder, or spinal degeneration, stem cell therapy should not be described as something that ‘creates a new joint’ or ‘replaces the spine.’ Instead, it is better explained as providing support to the biological environment around the affected tissues.
Stem cell therapy may provide support through several proposed mechanisms:
Helping regulate inflammation related to pain and stiffness
Supporting paracrine signaling between cells
Supporting the microenvironment around joints, tendons, muscles, and surrounding soft tissues
Helping reduce systemic inflammatory stress, especially in patients with multi-site symptoms
Supporting tissue recovery together with rest, movement, rehabilitation, and follow-up care
When it comes to foraminal stenosis or nerve root compression, stem cell therapy should not be described as a way to open the nerve canal or fix narrowing, as surgery does. Instead, it should be seen as supportive care that may help lower inflammation and improve the tissue environment. In the course, the patient received an individualized treatment plan using human umbilical cord-derived mesenchymal stem cells (UC-MSCs), along with supportive therapies such as vitamin drips, NAD+, peptide therapy, growth factors, and PRP in selected areas.
The treatment plan aimed to give both overall and targeted support, since the patient’s symptoms affected many areas, not just one joint or region.
Treatment in December 2024
In December 2024, the patient received approximately 160 million MSCs in total.
This included:
IV UC-MSCs: approximately 45 million MSCs
Local injections: approximately 115 million MSCs
The purpose of this treatment was to support the whole body and specific problem areas. It focused on reducing inflammation, improving movement, and easing pain in the shoulders, hips, knees, ankles, and lower back.
In February 2025, the patient returned for additional treatment and received approximately 160 million MSCs in total.
This included:
IV UC-MSCs: approximately 40 million MSCs
Local spine injections: approximately 120 million MSCs
This treatment focused on alleviating symptoms in the neck and lower back while also continuing overall support through IV therapy.
Additional Treatment in February
Another treatment course documented additional local UC-MSC injections totaling approximately 50 million MSCs.
This included:
Local injections: approximately 50 million MSCs
This treatment aimed to help the spine and joints affected by chronic pain by using PRP in specific areas as needed.
Ongoing Care Plan in November 2025
A later treatment option in November 2025 outlined a continued care plan using approximately 160 million MSCs.
This included:
IV UC-MSCs: approximately 60 million MSCs
Local injections: approximately 100 million MSCs
This plan demonstrated a personalized, ongoing approach that accounted for the patient’s pain, movement goals, overall recovery, and long-term quality of life.
5. Patient-Reported Outcome and Feedback
After treatment, the patient noticed steady and clear improvement. About a month after the injections, she started to feel real changes. The pain that had made daily life difficult became much less, and she estimated her pain improved by about 80%. to move more comfortably, return to exercise, and live her daily life closer to the way she did before chronic pain became a major limitation. Pain in the back, hips, joints, and areas affecting mobility became less disruptive, allowing her to feel more confident using her body again.
Most importantly, the patient said she was very happy with the results. Her chronic pain had affected her body, movement, sleep, exercise, and quality of life for years. Being able to get back to daily activities and exercise more easily was a big improvement for her.
Patient-Reported Outcome
Pain improved by approximately 80%
Improvement began around one month after treatment.
The patient was able to return to exercise.
Movement became easier and more comfortable.
Daily life became closer to her pre-pain baseline.
The patient felt happier and more confident in daily living.
Reduced reliance on daily pain-relief strategies
These results are based on the patient’s self-report. Outcomes can vary from person to person and should not be assumed to be guaranteed for everyone.
6. Doctor’s Perspective
From a clinical perspective, this case illustrates why it is important to develop a treatment plan tailored to each patient. This patient did not have just one joint problem. She had chronic pain in several places, moderate to severe osteoarthritis in her left shoulder, a history of knee surgery, and MRI scans showing spinal degeneration, foraminal stenosis, and nerve root compression.
In a case like this, clinical evaluation should not rely only on MRI or X-ray findings. It should also consider the patient’s actual symptoms, pain level, mobility, sleep quality, exercise capacity, daily functioning, and overall quality of life.
Key clinical considerations include:
Chronic pain is often multifactorial, not caused by a single joint or structure.
Osteoarthritis, spinal degeneration, nerve root compression, and inflammatory signaling may all contribute to pain.
Patients with multi-site symptoms may require a plan that addresses both systemic factors and localized symptoms.
Stem cell therapy should be combined with realistic expectations, follow-up, and movement-based care.
Outcomes should be assessed using pain, mobility, stiffness, balance, exercise capacity, and quality of life.
Regenerative medicine outcomes may develop gradually over several weeks to months, so continued monitoring is important.
Conclusion
This case represents an individualized care approach for a patient with multi-site chronic pain, left shoulder osteoarthritis, spinal degeneration, foraminal stenosis, and mobility limitation. During the treatment course, the patient received UC-MSCs via both systemic IV infusion and local injections across multiple treatment periods. The goal was to support a balance among inflammation, mobility, and quality of life, not to guarantee new joint formation or to directly correct spinal structural narrowing.
After treatment, the patient reported improvement beginning around one month after the injections. Her pain decreased by approximately 80%, and she was able to return to exercise and daily activities closer to her pre-pain baseline.
This case shows how important it is to assess each patient individually, plan treatment carefully, and communicate honestly about results. Stem cell therapy can be a supportive option for some patients, but it should be offered responsibly, with a focus on safety, function, and quality of life.